/ EN

01 | Scientific Committee


MingMed Biotechnology R&D team features world class scientists and global industry leaders. The management team is comprised of senior managers and serial entrepreneurs from pharmaceutical company, investment firm and commercial organization. The core team members have known each other for more than 20 years with long standing trust.

Dimiter S. Dimitrov, Ph.D.

***** Dr. Dimiter Dimitrov is Director of Center for Antibody Therapeutics at Department of Medicine at University of Pittsburg. He obtained his Ph.D. in chemistry at the University of Sofia, and his Sc.D. in biology at the Bulgarian Academy of Sciences, where he was elected as a Professor of Biophysics. He was appointed to the Senior Biomedical Research Service at NIH and selected as an NCI outstanding mentor. He published over 400 peer reviewed articles and book chapters. He is the inventor of over 100 patents. His research focuses on development of human monoclonal antibodies including isolated engineered antibody domains for prevention and treatment of cancer and other diseases. Dr. Dimitrov and his research group are experts in display/screening/libraries methodologies, antibody engineering, and protein biochemistry, structural biology and computational biology as well as virology, immunology and cancer biology.

John W. Mellors, M.D

***** Dr. John Mellors is a Professor of Infectious Diseases and Microbiology, University of Pittsburgh Medical Center (UPMC), Endowed Chair at Glo

Scott M. Whitcup, M.D.

***** Dr. Scott Whitcup is the Founder and CEO of Akrivista. Previously, he was Chief Scientific Officer at Allergan, and served on the Board of Semnur Pharmaceuticals, Nightstar Therapeutics, Avanir Pharmaceuticals, and Questcor Pharmaceuticals. He has expertise in ophthalmology, CNS, urology, dermatology, medical aesthetics, anti-infectives, and obesity. He published over 200 peer reviewed articles and 150 patents. Dr. Whitcup holds a B.A. in Neurobiology and Behavior from Cornell University and an M.D. from Cornell University Medical College. He has completed a residency in Internal Medicine at UCLA, a residency in Ophthalmology at Harvard Medical School-Massachusetts Eye & Ear Infirmary and a fellowship in Uveitis and Ocular Immunology at the National Eye Institute, National Institutes of Health. He is a Diplomate of both the American Board of Institute, David Geffen School of Medicine at the University of California at Los Angeles. Dr. Whitcup also worked in leadership positions at the National Eye Institute at NIH.

Previous page

Home   丨   About Us   丨   Product and Pipeline   丨   Our Team   丨   News   丨   Career   丨   Contact

Address: 106 Fengze East Road, Nansha District, Guangzhou 
Email: ming-med@ming-med.com

Copyright © 2020 ming-med.com  保留所有权利  粤ICP备20029450号-1